Business Context and Reporting Period
This Form 8-K Current Report was filed by vTv Therapeutics Inc. on September 28, 2018. The filing addresses a corporate governance event rather than financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate event and does not contain financial statements.
Material Changes
The material change reported is the resignation of a member of the Board of Directors.
- Event: Resignation of Director.
- Individual: Paul M. Meister.
- Date: September 28, 2018.
- Details: Mr. Meister notified the Company of his resignation as a member of the Board of Directors.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of the director's departure.
Investor Verification Checklist
- Verify the effective date of Paul M. Meister's resignation.
- Check for any subsequent filings regarding the appointment of a replacement director.
- Review the Company's most recent 10-Q or 10-K for financial data, as this 8-K contains none.